July 17, 2026
EPS CEO Noriyuki Takai Featured in PharmaBoardroom
An interview with Noriyuki Takai, Representative Director of EPS Corporation, has been published in PharmaBoardroom, an international publication covering the global pharmaceutical and healthcare industry.
In the interview, Mr. Takai discusses the challenges of drug lag and drug loss in Japan, as well as EPS's initiatives to support overseas biotech and pharmaceutical companies entering the Japanese market.
The article also highlights EPS's integrated support capabilities across the drug development lifecycle, the newly launched EPS BIOPath service for overseas biotechs, its Asia-Pacific partnership strategy, the application of AI to improve clinical development efficiency, and the importance of talent development in supporting future growth.
We invite you to read the full interview and learn more about EPS's vision and commitment to advancing healthcare innovation.
Read the full interview
Contact Us
Share this page